Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provinces

Osteoporosis International

Volumn 25, Issue 1, 2014, Pages 205-210

  Crilly, R G ^a,c   Kloseck, M ^a   Chesworth, B ^a   Mequanint, S ^b   Sadowski, E ^a   Gilliland, J ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c PARKWOOD HOSPITAL   (Canada)

Author keywords

Hip fracture; Medication; Osteoporosis; Prescription rates

Indexed keywords

ALENDRONIC ACID; ETIDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; CANADA; FEMALE; FEMUR INTERTROCHANTERIC FRACTURE; GROUPS BY AGE; HIP FRACTURE; HORMONE SUBSTITUTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OSTEOPOROSIS; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; CANADA; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES;

EID: 84891854959     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2453-z     Document Type: Article

References (23)

1. Seeman E (2012) Nonvertebral fractures: as good as it gets? International Osteoporosis Foundation overview 12(2). www.iofbonehealth.org/volume-12-issue- 2. Accessed 30 January 2013
2. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier J, Reginster JY (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 334(5):333-340 (Pubitemid 32107641)
3. Lyles K, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799-1809 (Pubitemid 350044800)
4. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. JAMA 280(24):2077-2082 (Pubitemid 29014065)
5. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM (1993) Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 342(8837):72-75 (Pubitemid 23028113)
6. Cummings SR (1985) Are patients with hip fractures more osteoporotic? Review of the evidence. Am J Med 78(3):487-494 (Pubitemid 15107933)
7. Crilly RG, Cox L (2013) A comparison of bone density and bone morphology in those presenting with hip fractures, spinal fractures or a combination of the two. BMC Musculoskelet Disord 14:68. doi: 10.1186/1471-2474-14-68
8. Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, Nevitt MC, Cummings SR (2003) BMC at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 18(11):1947-1954 (Pubitemid 37377443)
9. Siris ES, Chen Y-T, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164(1):1108-1112 (Pubitemid 38668990)
10. Leslie WD, O'Donnell S, Jean S, Legacé C, Walsh P, Bancej C, Morin S, Hanley DA, Papaioannou A (2009) Trends in hip fracture rates in Canada. JAMA 302(8):883-889
11. Hartholt KA, Oudshoorn C, Zielinski SM, Burgers PT, Panneman MJ, van Beeck EF, Patka P (2011) The epidemic of hip fractures: are we on the right track? PLoS One 6(7):e22227. doi: 10.1371/journal.pone.0022227
12. Guerra-García MM, Rodríguez-Fernández JB, Puga-Sarmiento E, Charle-Crespo MÁ, Gomes-Carvalho CS, Prejigueiro-Santás A (2011) Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain. Aten Primaria 43(2):82-88. doi: 10.1016/j.aprim.2010.04.010, Epub 2010 Jun 15. Spanish
13. Nakamura N, Kyou T, Takaoka K, Ohzono K, Ono K (1992) Bone mineral density in the proximal femur and hip fracture type in the elderly. J Bone Miner Res 7(7):755-759
14. Osteoporosis Canada (2012) www.osteoporosis.ca/index.php/ci-id/5521/la- id/1.htm. Accessed 12 February 2013
15. Jones TM, Petrella RJ, Crilly R (2008) Determinants of persistence with weekly bisphosphonates in patients with osteoporosis. J Rheumatol 35(9):1865-1873
16. Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD (2010) clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. doi: 10.1503/cmaj.100771
17. Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) Does osteoporosis therapy invalidate FRAX® for fracture prediction? J Bone Miner Res 27:1243-1251
18. FRAX WHO Fracture Risk Assessment Tool http://www.shef.ac.uk/FRAX/tool.j Accessed 12 February 2013
19. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB (2004) Effect of vitamin D on falls. A meta-analysis. JAMA 291:1999-2006 (Pubitemid 38544282)
20. O'Loughlin JL, Robitaille Y, Boivin JF, Suissa S (1993) Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 137:342-352
21. Cummings SR, San Martin J, McClung MR, Siris E et al (2009) Denosumab for prevention of fractures in Postmenopausal women with osteoporosis. N Engl J Med 361:756-765
22. Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY (2008) Low incidence of anti-osteoporosis treatment after hip fracture. Bone Joint Surg Am 90(10):2142-2148
23. Jennings LA, Auerbach AD, Maselli J, Pekow PS, Lindenauer PK, Lee SJ (2010) Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture. J Am Geriatr Soc 58:650-657